IBDEI14M ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18086,1,3,0)
 ;;=3^DM Type 2 w/ Diab CKD
 ;;^UTILITY(U,$J,358.3,18086,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,18086,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,18087,0)
 ;;=E11.39^^88^909^28
 ;;^UTILITY(U,$J,358.3,18087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18087,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
 ;;^UTILITY(U,$J,358.3,18087,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,18087,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,18088,0)
 ;;=E11.41^^88^909^6
 ;;^UTILITY(U,$J,358.3,18088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18088,1,3,0)
 ;;=3^DM Type 2 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,18088,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,18088,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,18089,0)
 ;;=E11.42^^88^909^13
 ;;^UTILITY(U,$J,358.3,18089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18089,1,3,0)
 ;;=3^DM Type 2 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,18089,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,18089,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,18090,0)
 ;;=E11.43^^88^909^2
 ;;^UTILITY(U,$J,358.3,18090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18090,1,3,0)
 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,18090,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,18090,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,18091,0)
 ;;=E11.44^^88^909^1
 ;;^UTILITY(U,$J,358.3,18091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18091,1,3,0)
 ;;=3^DM Type 2 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,18091,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,18091,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,18092,0)
 ;;=E11.49^^88^909^8
 ;;^UTILITY(U,$J,358.3,18092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18092,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,18092,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,18092,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,18093,0)
 ;;=E11.59^^88^909^25
 ;;^UTILITY(U,$J,358.3,18093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18093,1,3,0)
 ;;=3^DM Type 2 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,18093,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,18093,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,18094,0)
 ;;=E11.610^^88^909^9
 ;;^UTILITY(U,$J,358.3,18094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18094,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,18094,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,18094,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,18095,0)
 ;;=E11.618^^88^909^26
 ;;^UTILITY(U,$J,358.3,18095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18095,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,18095,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,18095,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,18096,0)
 ;;=E11.621^^88^909^16
 ;;^UTILITY(U,$J,358.3,18096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18096,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,18096,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,18096,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,18097,0)
 ;;=E11.622^^88^909^31
 ;;^UTILITY(U,$J,358.3,18097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18097,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,18097,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,18097,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,18098,0)
 ;;=E11.628^^88^909^30
 ;;^UTILITY(U,$J,358.3,18098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18098,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Compl
